BriaCell Therapeutics Corp. (BCTX)
NASDAQ·Healthcare·Biotechnology
$4.05
+0.37%
Mkt Cap $7.08M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 10, 2026 | — | — | — | -$4.84 | -$2.58 | +46.69% | — | — |
| Q4 2025 Dec 11, 2025 | — | — | — | — | -$4.35 | — | — | — |
| Q4 2025 Oct 27, 2025 | — | — | — | -$12.11 | -$10.49 | +13.38% | — | — |
| Q2 2025 Jun 16, 2025 | — | — | — | -$17.60 | -$16.40 | +6.82% | — | — |
| Q1 2025 Mar 12, 2025 | — | — | — | -$19.40 | -$23.30 | -20.10% | — | — |
| Q4 2024 Dec 16, 2024 | — | — | — | -$0.30 | -$32.98 | -10893.33% | — | — |
| Q3 2024 Jul 31, 2024 | — | — | — | — | -$0.73 | — | — | — |
| Q2 2024 Jun 14, 2024 | — | — | — | -$82.46 | $16.49 | +120.00% | — | — |
| Q1 2024 Mar 18, 2024 | — | — | — | -$29.99 | -$106.45 | -254.95% | — | — |
| Q4 2023 Dec 14, 2023 | — | — | — | -$26.99 | -$74.96 | -177.73% | — | — |
| Q3 2023 Jul 31, 2023 | — | — | — | — | -$1.70 | — | — | — |
| Q2 2023 Jun 14, 2023 | — | — | — | -$53.97 | -$47.98 | +11.10% | — | — |
| Q1 2023 Mar 15, 2023 | — | — | — | -$55.47 | -$115.44 | -108.11% | — | — |
| Q4 2022 Dec 14, 2022 | — | — | — | -$49.48 | -$10.49 | +78.80% | — | — |
| Q3 2022 Jul 5, 2022 | — | — | — | -$0.19 | -$0.43 | -128.46% | — | — |
| Q2 2022 Jun 13, 2022 | — | — | — | -$28.49 | -$47.98 | -68.41% | — | — |
| Q1 2022 Mar 15, 2022 | — | — | — | -$25.49 | -$35.98 | -41.15% | — | — |
| Q4 2021 Dec 14, 2021 | — | — | — | — | -$22.49 | — | — | — |
| Q3 2021 Jul 31, 2021 | — | — | — | — | -$2735.77 | — | — | — |
| Q2 2021 Jun 29, 2021 | — | — | — | — | -$139.43 | — | — | — |